nitroglycerin has been researched along with cyclosporine in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (61.11) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 3 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Carrier, M; Pelletier, CL; Tronc, F | 1 |
Bittner, H; Bub, A; Forssmann, WG; Hetzer, R; Hummel, M; Kleefeld, D; Kuhn, M; Marxen, P; Schneider, B | 1 |
Carrier, M; Pelletier, LC; Stewart, D; Tronc, F | 1 |
Carrier, M; Pelletier, LC; Thai, P | 1 |
Carrier, M; Pelletier, LC; Stewart, D; Thai, P | 1 |
Costard-Jäckle, A; Cremer, J; Haverich, A; Herrmann, G; Simon, R | 1 |
Chatterjee, K; Chou, TM; De Groot, CJ; DeMarco, T; MacGregor, JS; Sudhir, K; Taylor, RN; Yock, PG | 1 |
de Ridder, L; Lameire, N; Van de Voorde, J; Verbeke, M | 1 |
Carrier, M; Khalil, A; Latour, JG; Pelletier, LC | 1 |
Carrier, M; Dupuis, J; Mathieu, P; Pelletier, LC; Ryan, J | 1 |
Braun-Dullaeus, RC; Feussner, M; Grimminger, F; Haberbosch, W; Hopmann, H; Kraemer, HJ; Tillmanns, H; Walker, G | 1 |
Serón, D | 1 |
Banas, B; Bergler, T; Böger, C; Krämer, BK; Krüger, B; Leingärtner, T; Mack, M; Weingart, C | 1 |
Baldus, S; Brandes, RP; Daiber, A; Gori, T; Hortmann, M; Mollnau, H; Müller, J; Münzel, T; Oelze, M; Schuhmacher, S; Schulz, E; Wenzel, P; Wickramanayake, JM | 1 |
Akopova, OV; Kolchyns'ka, LI; Korkach, IuP; Kotsiuruba, AV; Sagach, VF | 1 |
2 review(s) available for nitroglycerin and cyclosporine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cyclosporin A and transplant coronary disease after heart transplantation: facts and fiction.
Topics: Animals; Aorta; Coronary Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Follow-Up Studies; Heart Transplantation; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Nitroglycerin; Retrospective Studies; Risk Factors; Time Factors | 1994 |
2 trial(s) available for nitroglycerin and cyclosporine
Article | Year |
---|---|
Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients.
Topics: Acute Kidney Injury; Adult; Atrial Natriuretic Factor; Blood Pressure; Catecholamines; Cyclosporine; Diuretics; Female; Furosemide; Heart Rate; Heart Transplantation; Humans; Kidney Function Tests; Male; Middle Aged; Nitroglycerin; Peptide Fragments; Postoperative Care; Renal Dialysis | 1992 |
Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: a study in patients with stable renal allograft function.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Nitroglycerin; Renal Artery; Tacrolimus; Vascular Resistance; Vasodilator Agents | 2006 |
14 other study(ies) available for nitroglycerin and cyclosporine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mechanism of hind limb vasoconstriction due to cyclosporin A in the dog.
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Cyclosporine; Dogs; Hindlimb; Nitroglycerin; Norepinephrine; Reflex; Sympathectomy; Tyramine; Vasoconstriction | 1992 |
Dose-dependent effect of cyclosporin on renal arterial resistance in dogs.
Topics: Animals; Blood; Cyclosporine; Diltiazem; Dogs; Dose-Response Relationship, Drug; Endothelins; Kidney; Nitric Oxide; Nitroglycerin; Phentolamine; Receptors, Adrenergic, alpha; Renal Artery; Renal Veins; Sympathectomy; Vascular Resistance | 1991 |
Vasoconstrictor effect of cyclosporin on the mesenteric artery in the dog.
Topics: Animals; Blood Flow Velocity; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Infusions, Intra-Arterial; Mesenteric Arteries; Nitroglycerin; Perfusion; Phentolamine; Receptors, Adrenergic, alpha; Vasoconstriction | 1994 |
Do triglyceride and low-density lipoprotein blood levels affect the vascular response to cyclosporine?
Topics: Acetylcholine; Animals; Blood Pressure; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Hindlimb; Lipoproteins, LDL; Muscle, Smooth, Vascular; Nitroglycerin; Norepinephrine; Renal Artery; Triglycerides; Vasodilation | 1994 |
Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries.
Topics: Acetylcholine; Animals; Arginine; Arteries; Coronary Circulation; Coronary Vessels; Cyclosporine; Dogs; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Pericardium; Vascular Resistance; Vasodilation | 1994 |
Regional differences in vasculotoxic effects of cyclosporin in rats.
Topics: Acetylcholine; Animals; Aorta; Carotid Arteries; Cyclosporine; Endothelium, Vascular; Immunosuppressive Agents; In Vitro Techniques; Kidney Diseases; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitroglycerin; Nitroprusside; Rats; Rats, Wistar; Renal Artery; Vascular Diseases; Vasodilator Agents | 1995 |
Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms.
Topics: Acetylcholine; Adenosine; Animals; Arginine; Coronary Circulation; Coronary Vessels; Cyclosporine; Dogs; Endothelium, Vascular; Female; Hemodynamics; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Nitroglycerin; Vasoconstriction | 1996 |
L-arginine prevents cyclosporin A-induced pulmonary vascular dysfunction.
Topics: Acetylcholine; Animals; Arginine; Atrial Function, Left; Blood Pressure; Bradykinin; Cyclooxygenase Inhibitors; Cyclosporine; Dogs; Endothelium, Vascular; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroglycerin; Peptidyl-Dipeptidase A; Pulmonary Artery; Pulmonary Circulation; Substance P; Vasodilation; Vasodilator Agents | 1997 |
Cyclosporine-induced coronary artery constriction--dissociation between thromboxane release and coronary vasospasm.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Vasospasm; Coronary Vessels; Cyclooxygenase Inhibitors; Cyclosporine; Endothelium, Vascular; Heart; Heart Rate; Immunosuppressive Agents; Male; Myocardial Contraction; Myocardium; Nifedipine; Nitric Oxide Donors; Nitroglycerin; Pharmaceutical Vehicles; Polyethylene Glycols; Prostanoic Acids; Rats; Rats, Wistar; Receptors, Thromboxane; Thromboxane B2; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Management of cardiovascular risk in patients receiving calcineurin inhibitors--a case report.
Topics: Acenocoumarol; Amiodarone; Angioplasty; Calcineurin Inhibitors; Carbazoles; Carvedilol; Cyclosporine; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Immunosuppressive Agents; Indoles; Kidney Transplantation; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Postoperative Complications; Pravastatin; Prednisone; Propanolamines; Risk Factors; Tacrolimus; Treatment Outcome | 2006 |
First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction.
Topics: Animals; Aorta; Blotting, Western; Cell Line; Chromatography, High Pressure Liquid; Cyclosporine; Ethidium; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; NADPH Oxidases; Nitroglycerin; Rats; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rotenone; Transfection; Vasoconstriction; Vasodilator Agents | 2008 |
[Reactive nitrogen and oxygen species metabolism in rat heart mitochondria upon administration of NO donor in vivo].
Topics: Animals; Calcium; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrogen Peroxide; Injections, Intraperitoneal; Iron; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Nitroglycerin; Oxidation-Reduction; Oxidoreductases; Peroxynitrous Acid; Rats; Rats, Wistar; Reactive Oxygen Species | 2012 |